Status:
UNKNOWN
Endoscopic Treatment of Non-variceal Upper GI-bleeding With High Risk of Recurrency - OTSC (Over-the-scope-clip) Versus Standard Therapy (STING2)
Lead Sponsor:
Kliniken Ludwigsburg-Bietigheim gGmbH
Collaborating Sponsors:
University Hospital Freiburg
University Hospital Ulm
Conditions:
Acute Upper Gastrointestinal Hemorrhage
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Prospective-randomized multi-center trial. Patients with high risk of recurrent GI-bleeding (non-variceal) are identified and randomized into either endoscopic treatment with the OTSC \[Over The Scope...
Detailed Description
Prospective-randomized multi-center trial. Patients with high risk of recurrent GI-bleeding (non-variceal) are identified (Rockall Score \> 6) and randomized into either endoscopic treatment with the ...
Eligibility Criteria
Inclusion
- upper GI-bleeding (non-variceal) with high risk of recurrency
- 18 years and older
Exclusion
- variceal-bleeding
- under 18 years
- pregnancy or nursing period
- malignancy
- need for surgical treatment (for example perforation with peritonitis)
Key Trial Info
Start Date :
September 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2019
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03331224
Start Date
September 1 2017
End Date
September 1 2019
Last Update
November 6 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinikum Ludwigsburg
Ludwigsburg, Germany